i
Drug abuse treatment as AIDS prevention.
-
Jun 1998
Source: Public Health Rep. 113(Suppl 1):97-106
Details:
-
Alternative Title:Public Health Rep
-
Personal Author:
-
Description:As the acquired immunodeficiency syndrome (AIDS) epidemic among drug users enters its third decade in the United States, it is important to consider the role playing by substance abuse treatment in the prevention of human immunodeficiency virus (HIV) infection.|The authors review the research literature, examining findings from studies with behavioral and serologic measures on the association among treatment participation, HIV risk reduction, and HIV infection.|Numerous studies have now documented that significantly lower rates of drug use and related risk behaviors are practiced by injecting drug users (IDUs) who are in treatment. Importantly, these behavioral differences, based primarily on self-report, are consistent with studies that have examined HIV seroprevalence and seroincidence among drug users.|The underlying mechanism of action suggested by the collective findings of the available literature is rather simple-- individuals who enter and remain in treatment reduce their drug use, when leads to fewer instances of drug-related risk behavior. This lower rate of exposure results in fewer infections with HIV. The protective effects of treatment, however, can only be achieved when programs are accessible and responsive to the changing needs of drug users. Future research needs to be directed at developing a better understanding of the factors that enhance treatment entry and retention.
-
Subjects:
-
Pubmed ID:9722815
-
Pubmed Central ID:PMCnull
-
Document Type:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:urn:sha256:d98f3094cb3da0951a3b377c27d0fc2c258ba623275e06a79dc8669d33669dc2
-
Download URL:
-
File Type:
Supporting Files
-
No Additional Files
More +
Related Documents
-
Personal Author:Singer, M ;Baer, H A...06/01/1998 | Public Health Rep. 113(Suppl 1):81-89Description:To break the link between drug use and the human immunodeficiency virus (HIV), in 1992 the state of Connecticut rescinded a 14-year ban on pharmacy sa...Personal Author:Cottler, L B ;Compton, W M...06/01/1998 | Public Health Rep. 113(Suppl 1):31-41Description:The purpose of this chapter is to describe the results of a randomized study (funded by the National Institute on Drug Abuse [NIDA]) comparing a peer-...Personal Author:Kumar, M S ;Mudaliar, S...06/01/1998 | Public Health Rep. 113(Suppl 1):58-66Description:Community-based outreach to drug injectors is an important component of human immunodeficiency virus (HIV) prevention strategy. The purpose of this ch...Personal Author:Coyle, S L ;Needle, R H...06/01/1998 | Public Health Rep. 113(Suppl 1):19-30Description:Over the past decade, a body of observational research has accrued about the effects of outreach-based human immunodeficiency virus (HIV) intervention...Personal Author:Levy, J A ;Fox, S EJun 1998 | Public Health Rep. 113(Suppl 1):160-169Description:This analysis describes the Outreach-Assisted Model of Partner Notification, an innovative strategy for encouraging seropositive injecting drug users ...Personal Author:Broadhead, R S ;Heckathorn, D D...Jun 1998 | Public Health Rep. 113(Suppl 1):42-57Description:Since 1985, community outreach efforts to combat acquired immunodeficiency syndrome (AIDS) among injecting drug users (IDUs) in the United States have...Personal Author:Vlahov, D ;Junge, BJun 1998 | Public Health Rep. 113(Suppl 1):75-80Description:Injecting drug users (IDUs) are at high risk for infection by human immunodeficiency virus (HIV) and other blood-borne pathogens. In the United States...Personal Author:Des Jarlais, D C ;Friedman, S RJun 1998 | Public Health Rep. 113(Suppl 1):182-188Description:Acquired immunodeficiency syndrome (AIDS) was formally identified among injecting drug users (IDUs) in 1981, and research on preventing human immunode...Personal Author:Shriver, M ;de Burger, R...Jun 1998 | Public Health Rep. 113(Suppl 1):189-193Description:Five policy advocates and practitioners provide recommendations to researchers to make research data more usable, accessible, and applicable for the f...Personal Author:Booth, R E ;Kwiatkowski, C...Jun 1998 | Public Health Rep. 113(Suppl 1):116-128Description:High risk injection practices are common among injecting drug users (IDUs), even following intervention efforts. Moreover, relapse to risk behaviors h...Personal Author:Brooner, R ;Kidorf, M...Jun 1998 | Public Health Rep. 113(Suppl 1):129-139Description:Although lowering incidence rates of human immunodeficiency virus (HIV) transmission is the primary goal of needle exchange programs (NEPs), other des...Personal Author:Hartel, D M ;Schoenbaum, E EJun 1998 | Public Health Rep. 113(Suppl 1):107-115Description:We undertook a study of the role of methadone maintenance in protecting injecting drug users (IDUs) from human immunodeficiency virus (HIV) infection ...Personal Author:Ball, A L ;Rana, S...Jun 1998 | Public Health Rep. 113(Suppl 1):170-181Description:Human immunodeficiency virus (HIV) infection associated with injecting drug use has been reported in at least 98 countries and territories worldwide. ...Personal Author:Valente, T W ;Foreman, R K...Jun 1998 | Public Health Rep. 113(Suppl 1):90-96Description:Our first objective was to develop an index of satellite exchange and then determine whether satellite exchangers (SEs) differed demographically or be...Personal Author:Latkin, C AJun 1998 | Public Health Rep. 113(Suppl 1):151-159Description:Guided by a social influence and empowerment framework, peer leaders in the injecting drug user (IDU) community were trained to promote human immunode...
More +
You May Also Like
Personal Author:
Hartel, D M ;
Schoenbaum, E E
Jun 1998 | Public Health Rep. 113(Suppl 1):107-115
Description:
We undertook a study of the role of methadone maintenance in protecting injecting drug users (IDUs) from human immunodeficiency virus (HIV) infection ...
Personal Author:
Latkin, C A
Jun 1998 | Public Health Rep. 113(Suppl 1):151-159
Description:
Guided by a social influence and empowerment framework, peer leaders in the injecting drug user (IDU) community were trained to promote human immunode...
Checkout today's featured content at stacks.cdc.gov